156 related articles for article (PubMed ID: 17266880)
1. [Fibrogenesis and inflammatory bowel disease].
Sans M; Masamunt MC
Gastroenterol Hepatol; 2007 Jan; 30(1):36-41. PubMed ID: 17266880
[TBL] [Abstract][Full Text] [Related]
2. Intestinal fibrosis in Crohn's disease: role of microRNAs as fibrogenic modulators, serum biomarkers, and therapeutic targets.
Lewis A; Nijhuis A; Mehta S; Kumagai T; Feakins R; Lindsay JO; Silver A
Inflamm Bowel Dis; 2015 May; 21(5):1141-50. PubMed ID: 25636122
[TBL] [Abstract][Full Text] [Related]
3. Pathogenic aspects and therapeutic avenues of intestinal fibrosis in Crohn's disease.
Zorzi F; Calabrese E; Monteleone G
Clin Sci (Lond); 2015 Dec; 129(12):1107-13. PubMed ID: 26494636
[TBL] [Abstract][Full Text] [Related]
4. [Susceptibility genes and serum markers of intestinal fibrosis in Crohn disease].
Li G; Ren J; Li J
Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Nov; 20(11):1326-1330. PubMed ID: 29178104
[TBL] [Abstract][Full Text] [Related]
5. Elafin Reverses Intestinal Fibrosis by Inhibiting Cathepsin S-Mediated Protease-Activated Receptor 2.
Xie Y; Fontenot L; Chupina Estrada A; Nelson B; Wang J; Shih DQ; Ho W; Mattai SA; Rieder F; Jensen DD; Bunnett NW; Koon HW
Cell Mol Gastroenterol Hepatol; 2022; 14(4):841-876. PubMed ID: 35840034
[TBL] [Abstract][Full Text] [Related]
6. [Intestinal flora and Crohn's disease].
Desreumaux P; Colombel JF
Ann Pharm Fr; 2003 Jul; 61(4):276-81. PubMed ID: 12843962
[TBL] [Abstract][Full Text] [Related]
7. Can we influence fibrosis in Crohn's disease?
Assche GV
Acta Gastroenterol Belg; 2001; 64(2):193-6. PubMed ID: 11475134
[TBL] [Abstract][Full Text] [Related]
8. Predictors of fibrostenotic Crohn's disease.
Rieder F; Lawrance IC; Leite A; Sans M
Inflamm Bowel Dis; 2011 Sep; 17(9):2000-7. PubMed ID: 21308880
[TBL] [Abstract][Full Text] [Related]
9. Crohn's disease complicated by strictures: a systematic review.
Rieder F; Zimmermann EM; Remzi FH; Sandborn WJ
Gut; 2013 Jul; 62(7):1072-84. PubMed ID: 23626373
[TBL] [Abstract][Full Text] [Related]
10. Metabolic modulation during intestinal fibrosis.
Bos S; Laukens D
J Dig Dis; 2020 Jun; 21(6):319-325. PubMed ID: 32406133
[TBL] [Abstract][Full Text] [Related]
11. Autophagy Stimulation as a Potential Strategy Against Intestinal Fibrosis.
Cosin-Roger J; Canet F; Macias-Ceja DC; Gisbert-Ferrándiz L; Ortiz-Masiá D; Esplugues JV; Alós R; Navarro F; Barrachina MD; Calatayud S
Cells; 2019 Sep; 8(9):. PubMed ID: 31540207
[TBL] [Abstract][Full Text] [Related]
12. Fibrogenesis. IV. Fibrosis and inflammatory bowel disease: cellular mediators and animal models.
Pucilowska JB; Williams KL; Lund PK
Am J Physiol Gastrointest Liver Physiol; 2000 Oct; 279(4):G653-9. PubMed ID: 11005750
[TBL] [Abstract][Full Text] [Related]
13. The Oxysterol Synthesising Enzyme CH25H Contributes to the Development of Intestinal Fibrosis.
Raselli T; Wyss A; Gonzalez Alvarado MN; Weder B; Mamie C; Spalinger MR; Van Haaften WT; Dijkstra G; Sailer AW; Imenez Silva PH; Wagner CA; Tosevski V; Leibl S; Scharl M; Rogler G; Hausmann M; Misselwitz B
J Crohns Colitis; 2019 Sep; 13(9):1186-1200. PubMed ID: 31220227
[TBL] [Abstract][Full Text] [Related]
14. Crohn's disease patients carrying Nod2/CARD15 gene variants have an increased and early need for first surgery due to stricturing disease and higher rate of surgical recurrence.
Alvarez-Lobos M; Arostegui JI; Sans M; Tassies D; Plaza S; Delgado S; Lacy AM; Pique JM; Yagüe J; Panés J
Ann Surg; 2005 Nov; 242(5):693-700. PubMed ID: 16244543
[TBL] [Abstract][Full Text] [Related]
15. Crohn's disease associated strictures.
Chan WPW; Mourad F; Leong RW
J Gastroenterol Hepatol; 2018 May; 33(5):998-1008. PubMed ID: 29427364
[TBL] [Abstract][Full Text] [Related]
16. Serum biomarkers of fibrostenotic Crohn's disease: Where are we now?
He JS; Tan JY; Li XZ; Feng R; Xiong SS; Lin SN; Qiu Y; Mao R
J Dig Dis; 2020 Jun; 21(6):336-341. PubMed ID: 32496631
[TBL] [Abstract][Full Text] [Related]
17. Recent advances in intestinal fibrosis.
Lenti MV; Santacroce G; Broglio G; Rossi CM; Di Sabatino A
Mol Aspects Med; 2024 Apr; 96():101251. PubMed ID: 38359700
[TBL] [Abstract][Full Text] [Related]
18. Significant contribution of TRPC6 channel-mediated Ca
Kurahara LH; Hiraishi K; Sumiyoshi M; Doi M; Hu Y; Aoyagi K; Jian Y; Inoue R
J Smooth Muscle Res; 2016; 52(0):78-92. PubMed ID: 27818466
[TBL] [Abstract][Full Text] [Related]
19. NOD2/CARD15, NOD1/CARD4, and ICAM-1 gene polymorphisms in Turkish patients with inflammatory bowel disease.
Ozen SC; Dagli U; Kiliç MY; Törüner M; Celik Y; Ozkan M; Soykan I; Cetinkaya H; Ulker A; Ozden A; Bozdayi AM
J Gastroenterol; 2006 Apr; 41(4):304-10. PubMed ID: 16741608
[TBL] [Abstract][Full Text] [Related]
20. [Parenteral symptoms and intestinal complications in children with inflammatory bowel diseases in relation to card15 mutation].
Grzybowska-Chlebowczyk U; Woś H; Sieroń AL; Kajor M; Wiecek S; Koryciak-Komarska H; Auguściak-Duma A
Med Wieku Rozwoj; 2008; 12(3):754-60. PubMed ID: 19305026
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
